|
|
|
Volumn 158, Issue 46, 2014, Pages
|
|
Prostate cancer screening benefit very low, even after 13 years;Opbrengst prostaatkankerscreening zeer laag
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER SCREENING;
NOTE;
PROSTATE CANCER;
BLOOD;
COST BENEFIT ANALYSIS;
EARLY DIAGNOSIS;
HUMAN;
MALE;
MASS SCREENING;
MORTALITY;
POSTOPERATIVE COMPLICATION;
PROCEDURES;
PROSTATIC NEOPLASMS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
STATISTICS AND NUMERICAL DATA;
PROSTATE SPECIFIC ANTIGEN;
TUMOR MARKER;
COST-BENEFIT ANALYSIS;
EARLY DETECTION OF CANCER;
HUMANS;
MALE;
MASS SCREENING;
POSTOPERATIVE COMPLICATIONS;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 84911372272
PISSN: 00282162
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|